The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPC.L Regulatory News (BPC)

  • There is currently no data for BPC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issuance of Ordinary Shares, Options and Warrants

15 Oct 2020 07:00

RNS Number : 1783C
Bahamas Petroleum Company PLC
15 October 2020
 

15 October 2020

Bahamas Petroleum Company plc

("BPC" or the "Company")

Issuance of Ordinary Shares, Options and Warrants

BPC, the Caribbean and Atlantic margin focused oil and gas company, with exploration, production, appraisal and development assets across the region, advises of the issuances of: i) new ordinary shares of 0.002p each in the Company ("Ordinary Shares"), related to previously announced and shareholder approved salary deferrals; ii) new Ordinary Shares and warrants to subscribe for new Ordinary Shares in respect of certain adviser payment arrangements; iii) previously unallocated options over new Ordinary Shares from existing shareholder approved schemes; and iv) potential issue of new Ordinary Shares to executive and management conditional on certain performance criteria related to operations in Trinidad and Tobago being met.

Deferred Pay Shares

On 17 December 2014, the Directors entered into an agreement for the deferral of 20% of their salaries and fees. On 1 April 2016, the Directors entered into a further agreement for the deferral of 50% of their fees and the CEO entered into an agreement for the deferral of 90% of his salary, with half of this deferral accruing into an entitlement to shares and the other half accruing into an entitlement to cash. On 1 January 2018 the Directors (excluding the CEO) entered into a further agreement for the deferral of 90% of their fees, with half of this deferral accruing into an entitlement to shares and the other half accruing into an entitlement to cash.

 

In all cases, the terms of these deferrals were advised to the market. However, in summary, the deferrals related to fees and salaries being forgone until completion of a farmout or other arrangement sufficient to finance the Company's first exploration well in the Bahamas. Where applicable, the value of fees/salary forgone accrued at the end of each month as an entitlement to new Ordinary Shares in the Company, calculated as the value of fees/salary forgone divided by the volume weighted average closing share price on AIM of the Company's Ordinary Shares each month. Determination of whether the first exploration well had been sufficiently funded was defined as the Company either securing a farm-in or securing capital via debt and/or equity in excess of US$25 million, or any combination thereof. It was also subsequently determined that the Board would consult with the Company's relevant advisers on the adequacy of well funding prior to determining that the criteria had been met. Several members of the Company's executive team and staff had also agreed to a deferral of salary entitlements on a comparable basis.

 

In August 2019, shareholders were advised that the total number of deferred shares owed by the Company to Directors and certain other executives and staff members under this arrangement amounted to 116,698,188. Further, shareholders approved the issuance of this number of Ordinary Shares as and when the initial exploration well was considered fully funded and following consultation with the Company's relevant advisers. These entitlements included amounts due up to 31 July 2019. The circular that set out these proposals and which was posted to shareholders on 21 August 2019 explained that deferred payment obligations accruing from 1 August 2019 onwards would be payable in cash or shares at the Company's discretion, with all relevant Directors and members of management agreeing that any deferred shares would also be issued when the initial well was determined to be fully funded. The Company has elected to settle its obligations to Directors and management for the period 1 August 2019 to 30 September 2020 in Ordinary Shares amounting to 30,120,577 shares, such that the total aggregate number of accrued deferred pay shares as at 1 October 2020 amounted to 146,818,765 Ordinary Shares (the "Deferred Pay Shares").

 

Further to the US$12 million equity placing as announced on 1 October 2020 (the "Placing"), the Board, having consulted with the Company's relevant advisers, has determined that the initial exploration well is fully funded per the established criteria. As such, the Company will proceed to issue 146,818,765 Deferred Pay Shares, in aggregate, as follows:

 

DIRECTORS

Deferred Pay Shares

Bill Schrader

14,155,667

James Smith

9,255,630

Simon Potter

63,567,276

Adrian Collins

10,888,977

Ross McDonald

9,255,630

Leo Koot

289,970

Total Deferred Pay Shares issued to Directors

107,413,150

Management & Former Directors(1)

39,405,615

TOTAL DEFERRED PAY SHARES ISSUED

146,818,765

(1) Includes accrued shares owing to the Estate of Mr. Shallcross (former Director) who passed away on 15 October 2019.

 

Given the determination that the initial exploration well is fully funded, all fee and salary deferral arrangements have now ceased, effective 1 October 2020.

 

Issuance of Shares and Warrants to Advisers

In relation to the Placing, the Company had agreed to the payment of brokerage fees to various placing advisers in the form of cash and warrants.

 

In relation to cash fees payable, certain of the Company's advisers have agreed to receive Ordinary Shares in the Company in lieu of those cash fees, with such Ordinary Shares to be issued on the same basis as shares were issued to investors in the institutional placing (being at a price of 2 pence per share). Consequently, the Company is issuing 7,733,592 Ordinary Shares (the "Adviser Fee Shares") in part settlement of cash fees otherwise payable in respect of the Placing.

 

The Company also agreed to issue 20,677,362 warrants in relation to brokerage fees for the Placing. These warrants are valid for two years from the date of grant and with an exercise price of 2 pence per share. If exercised, these warrants would result in gross proceeds being received by the Company of approximately £414,000.

 

Issuance of Options to Management

The Board's Remuneration Committee has resolved to make the following award of unallocated share options under the Company's existing approved option arrangements:

 

To the CEO:

- Award immediately of 6,250,000 Series B Options; and

- Award of 6,250,000 Series B Options, such award to be made and take effect once the Goudron EPSC in Trinidad has been fully executed and become effective.

 

To various members of the Company's executive and management:

- Award immediately of, in aggregate, 6,250,000 Series B Options;

- Award of, in aggregate, 6,250,000 Series B Options, such award to be made and take effect once the Goudron EPSC in Trinidad has been fully executed and become effective; and

- Award immediately of, in aggregate, 8,300,000 Series C Options.

 

Consequently, the Series B Option pool has been fully allocated and 8,000,000 options remain available for allocation from the Series C pool.

 

Conditional Bonus Payments to Management

The Board's Remuneration Committee has resolved to make the following performance related bonus payments to the CEO and a member of the Company's executive and management:

 

To the CEO:

- US$200,000, such award to be made and take effect only once the Goudron EPSC in Trinidad has been fully executed and becomes effective.

 

To a member of the Company's executive and management:

- US$200,000, such award to be made and take effect only once the Goudron EPSC in Trinidad has been fully executed and becomes effective.

 

The above recipients have agreed that they would be willing to receive such bonus payments in the form of Ordinary Shares, to be issued at such time as the Goudron EPSC performance criteria is met.

 

Aggregate Information

Directors' Holdings

Following the issue of the Deferred Pay Shares and options to Directors as described above, and inclusive of shares and options already held by Directors, the aggregate position held by the Directors is as follows:

DIRECTORS

TOTAL SHARES

SERIES A OPTIONS(1)

SERIES B OPTIONS(2)

SERIES C OPTIONS(3)

Bill Schrader

17,845,667

1,500,000

750,000

750,000

James Smith

11,475,630

750,000

375,000

375,000

Simon Potter(5)

76,119,214

20,000,000

27,500,000(4)

25,000,000

Adrian Collins

13,528,977

750,000

375,000

375,000

Ross McDonald

11,725,630

750,000

375,000

375,000

Leo Koot

19,514,077

nil

nil

nil

 

(1) Series A options are exercisable at 2.22 pence per share

(2) Series B options are exercisable at 2.4 pence per share

(3) Series C options are exercisable at 2.8 pence per share at such point in time as the initial exploration well commences (defined as once a rig is mobilised, that being when the contracted drilling rig, following inspection by BPC and any necessary customs authorisations, leaves the port of origination by a distance of 1 nautical mile)

(4) The award of 6,250,000 of these options remain conditional on the Goudron EPSC in Trinidad being fully executed and becoming effective

(5) This will increase to reflect the issuance of additional ordinary shares in lieu of agreed bonus at such time as the Goudron EPSC in Trinidad is fully executed and becomes effective

Total Voting Rights

Application will be made for the Deferred Pay Shares and Adviser Fee Shares to be admitted to trading on the AIM market of the London Stock Exchange ("AIM") and it is expected that admission will take place and trading in the shares will commence from 8.00 a.m. on or around 21 October 2020 ("Admission").

Upon Admission, the Company's issued share capital will consist of 4,049,360,203 Ordinary Shares, with each Ordinary Share carrying the right to one vote. The Company does not hold any Ordinary Shares in treasury. This figure of 4,049,360,203 Ordinary Shares may therefore be used by shareholders in the Company, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Total Options and Warrants on issue

Following the issuances of the options and warrants announced herein, the total options and warrants outstanding in the Company are as follows:

 

SERIES A OPTIONS(1)

SERIES B OPTIONS(2)

SERIES C OPTIONS(3)

WARRANTS & OTHER OPTIONS(4)

Directors (6)

3,750,000

1,875,000

1,875,000

Nil

Executive, Management and other

46,250,000

73,125,000(5)

65,125,000

Nil

Advisers and others

nil

nil

nil

73,213,605

(1) Series A options are exercisable at 2.22 pence per share

(2) Series B options are exercisable at 2.4 pence per share

(3) Series C options are exercisable at 2.8 pence per share at such point in time as the initial exploration well commences (defined as once a rig is mobilised, that being when the contracted drilling rig, following inspection by BPC and any necessary customs authorisations, leaves the port of origination by a distance of 1 nautical mile)

(4) Warrants & Other Options include warrants issued to Company advisers and options issued to finance providers and former executives of Columbus Energy Resources plc

(5) The award of 12,500,000 of these options remain conditional on the Goudron EPSC in Trinidad being fully executed and becoming effective

(6) For the purposes of this table those totals pertaining to Simon Potter, CEO, and the Estate of Mr Shallcross (former Director) who passed away on 15 October 2019, are included with the line item Executive, Management and other

If all options and warrants were to become exercisable and then exercised in accordance with their terms, gross proceeds received by the Company would be approximately £6.1 million.

 

For further information, please contact:

 

Bahamas Petroleum Company plc

Simon Potter, Chief Executive Officer

Tel: +44 (0) 1624 647 882

Strand Hanson Limited - Nomad

Rory Murphy / James Spinney / Jack Botros

Tel: +44 (0) 20 7409 3494

Shore Capital Stockbrokers Limited - Joint Broker

Jerry Keen / Toby Gibbs

 

Tel: +44 (0) 207 408 4090

Investec Bank Plc - Joint Broker

Chris Sim / Rahul Sharma

Tel: +44 (0) 207 597 5970

CAMARCO

Billy Clegg / James Crothers / Hugo Liddy

 Tel: +44 (0) 020 3757 4980

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to editors

 

BPC is a Caribbean and Atlantic margin focused oil and gas company, with a range of exploration, appraisal, development and production assets and licences, located offshore in the waters of The Bahamas and Uruguay, and onshore in Trinidad and Tobago, and Suriname. BPC is currently on-track for drilling an initial exploration well in The Bahamas, Perseverance #1, in late 2020 / early 2021, with the well targeting recoverable P50 prospective oil resources of 0.77 billion barrels, with an upside of 1.44 billion barrels. In Trinidad and Tobago, BPC has five producing fields, two appraisal / development projects and a prospective exploration portfolio in the South West Peninsula. BPC's exploration licence in Uruguay is highly prospective, with a potential resource of 1 billion barrels of oil equivalent. In Suriname, BPC has an onshore appraisal / development project.

 

BPC is listed on the AIM market of the London Stock Exchange.  www.bpcplc.com

  

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEMABATMTIBMLM
Date   Source Headline
20th May 202111:00 amRNSResult of Placing and Open Offer and TVR
19th May 20214:51 pmRNSResult of Open Offer and Proposed Placing
17th May 20211:23 pmRNSAppointment of Alternate Director & Result of EGM
13th May 20214:40 pmRNSSecond Price Monitoring Extn
13th May 20214:35 pmRNSPrice Monitoring Extension
13th May 20217:01 amRNSBoard and Management Participation in Fundraising
13th May 20217:00 amRNSProposed New Board Member and Saffron-2 Progress
11th May 20217:00 amRNSExtension of Open Offer Timetable
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 202111:05 amRNSSecond Price Monitoring Extn
6th May 202111:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSSaffron-2 -Rig Mobilisation and Operational Update
23rd Apr 20219:05 amRNSSecond Price Monitoring Extn
23rd Apr 20219:00 amRNSPrice Monitoring Extension
23rd Apr 20217:00 amRNSNotice of Extraordinary General Meeting
7th Apr 20214:40 pmRNSSecond Price Monitoring Extn
7th Apr 20214:35 pmRNSPrice Monitoring Extension
7th Apr 20212:06 pmRNSSecond Price Monitoring Extn
7th Apr 20212:00 pmRNSPrice Monitoring Extension
26th Mar 20217:00 amRNSUpdated Corporate Presentation
24th Mar 20217:00 amRNSHigh-Impact Exploration Update
18th Mar 20217:00 amRNSTrinidad and Tobago and Suriname Update
2nd Mar 20217:00 amRNSUpdate on Court Process in The Bahamas
16th Feb 20217:00 amRNSCorporate and Strategic Update
12th Feb 20214:40 pmRNSSecond Price Monitoring Extn
12th Feb 20214:35 pmRNSPrice Monitoring Extension
12th Feb 20212:06 pmRNSSecond Price Monitoring Extn
12th Feb 20212:00 pmRNSPrice Monitoring Extension
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSPerseverance #1 - Completion of Drilling
29th Jan 20215:45 pmRNSHolding(s) in Company
26th Jan 20217:00 amRNSIssue of Warrants
25th Jan 20217:10 amRNSResignation of Director
25th Jan 20217:00 amRNSUpdate on Court Process in The Bahamas
21st Jan 20219:05 amRNSSecond Price Monitoring Extn
21st Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20219:30 amRNSHolding(s) in Company
14th Jan 20219:35 amRNSHolding(s) in Company
12th Jan 20217:00 amRNSFunding Strategy: Reconciliation & Put Option
7th Jan 20217:00 amRNSPortfolio Operations and Funding Update
6th Jan 20217:00 amRNSUpdate on Court Process in The Bahamas
5th Jan 202112:29 pmRNSDirector Dealing
31st Dec 20207:00 amRNSFurther Update on Court Process in The Bahamas
30th Dec 20207:00 amRNSUpdate on Court Process in The Bahamas
29th Dec 20207:00 amRNSUpdate on Court Process in The Bahamas
22nd Dec 20201:00 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSExercise and Issuance of Warrants
21st Dec 20207:00 amRNSCommencement of the Drilling of Perseverance #1
16th Dec 20207:00 amRNSFunding Agreements for up to US$20 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.